Pregnancy and the Risk of Relapse in Patients Diagnosed With Hodgkin Lymphoma

被引:23
|
作者
Weibull, Caroline E. [1 ]
Eloranta, Sandra [1 ]
Smedby, Karin E. [1 ,2 ]
Bjorkholm, Magnus [2 ]
Kristinsson, Sigurdur Y. [2 ,4 ]
Johansson, Anna L. V. [1 ]
Dickman, Paul W. [1 ]
Glimelius, Ingrid [1 ,2 ,3 ]
机构
[1] Karolinska Inst, SE-17177 Stockholm, Sweden
[2] Karolinska Univ, Hosp Solna, Stockholm, Sweden
[3] Uppsala Univ, Uppsala, Sweden
[4] Univ Iceland, Reykjavik, Iceland
关键词
REGULATORY T-CELLS; FEMALE CANCER SURVIVORS; PROGNOSTIC-FACTOR; BREAST-CANCER; CARE PROGRAM; DISEASE; FERTILITY; SWEDEN; CHILDBEARING; PARENTHOOD;
D O I
10.1200/JCO.2015.63.3446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Many patients and clinicians are worried that pregnancy after the diagnosis of Hodgkin lymphoma (HL) may increase the risk of relapse despite a lack of empirical evidence to support such concerns. We investigated if an association exists between pregnancy and relapse in women with a diagnosis of HL. Materials and Methods Using Swedish healthcare registers combined with medical records, we included 449 women who received a diagnosis of HL between 1992 and 2009 and who were age 18 to 40 years at diagnosis. Follow-up started 6 months after diagnosis, when the patients' condition was assumed to be in remission. Pregnancy-associated relapse was defined as a relapse during pregnancy or within 5 years after delivery. Hazard ratios (HRs) with 95% CIs were estimated by using the Cox proportional hazards model. Results Among the 449 women, 144 (32%) became pregnant during follow-up. Overall, 47 relapses were recorded, of which one was a pregnancy-associated relapse. The adjusted HR for the comparison of the pregnancy-associated relapse rate to the non-pregnancy-associated relapse rate was 0.29 (95% CI, 0.04 to 2.18). The expected number of relapses in women with a recent pregnancy, given that they would experience the same relapse rate as that of women without a recent pregnancy, was 3.76; the observed-to-expected ratio was 0.27 (95% exact CI, 0.01 to 1.51). Conclusion We found no evidence that a pregnancy after diagnosis increases the relapse rate among women whose HL is in remission. Survivors of HL need to consider a range of factors when deciding about future reproduction. However, given the results of this study, the risk of pregnancy-associated relapse does not need to be considered.
引用
收藏
页码:337 / +
页数:10
相关论文
共 50 条
  • [1] Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma
    László Pinczés
    Zsófia Miltényi
    Árpád Illés
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 935 - 943
  • [2] Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma
    Pinczes, Laszlo
    Miltenyi, Zsofia
    Illes, Arpad
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (05) : 935 - 943
  • [3] Predictors of risk of relapse in classic Hodgkin lymphoma
    Fromm, Jonathan R.
    Tang, Claire
    Naresh, Kikkeri N.
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (06) : 414 - 417
  • [4] Evaluation of the Relapse Risk and Survival Rate in Patients with Hodgkin Lymphoma: A Monocentric Experience
    Potre, Ovidiu
    Pescaru, Monica
    Sima, Alexandra
    Ionita, Ioana
    Tudor, Raluca
    Borsi, Ema
    Samfireag, Miruna
    Potre, Cristina
    MEDICINA-LITHUANIA, 2021, 57 (10):
  • [5] Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
    Manson, G.
    Brice, P.
    Herbaux, C.
    Silva, M. G.
    Bouabdallah, K.
    Deau, B.
    Bouteloup, J.
    Schiano, J. M.
    Nicolas-Virelizier, E.
    Maerevoet, M.
    Ghesquieres, H.
    Stamatoullas, A.
    Antier, C.
    Carlo-Stella, C.
    de Charette, M.
    Poizeau, F.
    Dercle, L.
    Houot, Roch
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1144 - 1153
  • [6] Long-term outcomes for patients with Hodgkin lymphoma at increased risk of progression or relapse
    Kosydar, Samuel
    Ansell, Stephen M.
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 5 - 17
  • [7] Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
    G. Manson
    P. Brice
    C. Herbaux
    M. G. Silva
    K. Bouabdallah
    B. Deau
    J. Bouteloup
    J. M. Schiano
    E. Nicolas-Virelizier
    M. Maerevoet
    H. Ghesquieres
    A. Stamatoullas
    C. Antier
    C. Carlo-Stella
    M. de Charette
    F. Poizeau
    L. Dercle
    Roch Houot
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1144 - 1153
  • [8] EFFECTS OF BODY MASS INDEX AT DIAGNOSIS ON RELAPSE RISK IN PEDIATRIC HODGKIN LYMPHOMA PATIENTS
    Scotch, Allison
    Henry, Michael
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 95 - 95
  • [9] Relapse-localization in pediatric patients with Hodgkin lymphoma
    Lundgaard, A. Y.
    Hjalgrim, L. L.
    Berthelsen, A. K.
    Specht, L.
    Borgwardt, L.
    Maraldo, M. V.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S256 - S257
  • [10] Relapse-localization in pediatric patients with Hodgkin lymphoma
    Lundgaard, Chairs A. Y.
    Hjalgrim, L. L.
    Berthelsen, A. K.
    Specht, L.
    Borgwardt, L.
    Maraldo, M., V
    KLINISCHE PADIATRIE, 2020, 232 (02): : 106 - 106